Welcome to Central Library, SUST

Pharmacoepigenetics / (Record no. 85049)

MARC details
000 -LEADER
fixed length control field 05023cam a22006131i 4500
001 - CONTROL NUMBER
control field 022510864
003 - CONTROL NUMBER IDENTIFIER
control field BD-SySUS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230830111305.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu|||unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190607t20192019enk ob 001 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780128139400
Qualifying information (electronic bk.)
International Standard Book Number 0128139404
Qualifying information (electronic bk.)
Canceled/invalid ISBN 9780128139394
International Standard Book Number 0128139390
International Standard Book Number 9780128139394
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1103918307
Canceled/invalid control number (OCoLC)1229507269
-- (OCoLC)1235837465
040 ## - CATALOGING SOURCE
Original cataloging agency N$T
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency N$T
Modifying agency EBLCP
-- N$T
-- OPELS
-- OCLCF
-- UKMGB
-- UKAHL
-- OCLCQ
-- ERF
-- LVT
-- UX1
-- VT2
-- OCLCO
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM301.3.G45
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number 2019 G-375
Classification number QV 38.5
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.7
Edition number 23
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Cacabelos, R.
Fuller form of name (Ramón),
Dates associated with a name 1955-
Relator term author.
9 (RLIN) 63836
245 10 - TITLE STATEMENT
Title Pharmacoepigenetics /
Statement of responsibility, etc. Ramón Cacabelos.
250 ## - EDITION STATEMENT
Edition statement First edition.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture London :
Name of producer, publisher, distributor, manufacturer Academic Press, an imprint of Elsevier,
Date of production, publication, distribution, manufacture, or copyright notice [2019]
Date of production, publication, distribution, manufacture, or copyright notice ©2019
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Translational epigenetics series ;
Volume/sequential designation volume 10
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Front Cover; Pharmacoepigenetics; Copyright; Contents; Contributors; Pharmacoepigenetics: A Long Way Ahead; Chapter 1: The Epigenetic Machinery in the Life Cycle and Pharmacoepigenetics; 1.1. Introduction; 1.2. The Epigenetic Machinery; 1.2.1. DNA Methylation; 1.2.2. DNA Demethylation; 1.2.2.1. Ten-Eleven Translocation (TET) Proteins; 1.2.2.2. AID/APOBEC Family Cytidine Deaminases; 1.2.2.3. BER (Base Excision Repair) Glycosylases; 1.2.3. Chromatin Remodeling and Histone Modifications; 1.2.3.1. Chromatin; 1.2.3.1.1. Genome-Wide Chromatin Conformation, Spatial Organization, and 3D Genomics
Formatted contents note 1.2.3.2. Histones1.2.3.3. Posttranslational Modifications; 1.2.3.3.1. Histone Methylation-Demethylation; 1.2.3.3.2. Histone Acetylation; 1.2.3.3.3. Histone Deacetylation; Sirtuins; 1.2.3.3.4. Histone Acylation; 1.2.3.3.5. Histone Propionylation; 1.2.3.3.6. N-Glycosylation and O-GlcNAcylation; 1.2.3.3.7. Ubiquitination-Deubiquitination; 1.2.3.3.8. SUMOylation; 1.2.3.3.9. Histone Phosphorylation-Dephosphorylation; 1.2.3.3.10. Histone Chaperonization; 1.2.3.3.11. Glutathionylation; 1.2.3.3.12. Poly ADP-Ribosylation; 1.2.3.3.13. Oxidative Stress; 1.2.3.4. Other Posttranslational Changes
Formatted contents note 1.2.3.5. Noncoding RNAs1.2.3.5.1. miRNAs; 1.2.3.5.2. circRNAs; 1.2.3.5.3. RNA Methylation; 1.2.3.6. Other Operational Elements of the Epigenetic Machinery; 1.2.3.6.1. DNA Replication Regulators; 1.2.3.6.2. N6-Adenine DNA Methylation; 1.2.3.6.3. Transcription Factors; 1.2.3.6.4. Transcriptional Repression; 1.2.3.6.5. Polycomb Group Proteins: Polycomb Repressive Complex 2 (PRC2); 1.2.3.6.6. BET (Bromodomain and Extraterminal Domain) Proteins; 1.2.3.6.7. UHRF1; 1.2.3.6.8. Plant Homeodomain (PHD) Fingers; 1.2.3.6.9. HDACs; 1.2.3.6.10. Chromatin-Remodeling Factors
Formatted contents note 1.2.3.6.11. Heterochromatin and Gene Silencing1.2.3.6.12. MEN1; 1.2.3.6.13. NPC, HOXA, and Nup93; 1.2.3.6.14. CCR4; 1.2.3.6.15. HP1; 1.2.3.6.16. TORC1; 1.2.3.6.17. WDR5; 1.2.3.6.18. Nudt21; 1.2.3.6.19. Trithorax-Group Proteins; 1.2.3.6.20. SUUR Protein; 1.2.3.6.21. Kap123; 1.2.3.6.22. SET Complex; 1.2.3.6.23. Histone Code Reader Spin1; 1.2.3.6.24. Proteasome; 1.2.3.6.25. Lipid Mediators; 1.2.3.6.26. Transposable Elements; 1.2.3.6.27. Intragenic Enhancers; 1.2.3.6.28. Genomic Regulatory Regions; 1.3. Singular Epigenetic Phenomena; 1.3.1. Aneuploidy; 1.3.2. X Chromosome Inactivation
Formatted contents note 1.3.3. Meiotic Silencing1.3.4. RNA Splicing; 1.3.5. Copy Number Variation (CNV); 1.3.6. The Epigenetic Clock; 1.3.7. Epigenetic Reprogramming Memory; 1.3.8. Transgenerational Epigenetic Inheritance; 1.3.9. DNA Repair Pathways and Genomic Instability; 1.3.10. Antibody Maturation; 1.3.11. Sexual Dimorphism; 1.3.12. Heritable RNAi; 1.3.13. Genomic Imprinting; 1.4. Evolution; 1.5. Population Epigenetics; 1.6. Fertility and Gestation; 1.6.1. In Vitro Fertilization and Assisted Reproduction Technology; 1.7. Placenta; 1.8. Lactation; 1.9. Development; 1.10. Maturation, Aging, and Longevity
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Online resource; title from PDF title page (EBSCO, viewed June 10, 2019).
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacogenetics.
9 (RLIN) 63837
Topical term or geographic name as entry element Pharmacogenomics.
9 (RLIN) 63838
Topical term or geographic name as entry element Epigenetics.
9 (RLIN) 63839
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
9 (RLIN) 63840
Topical term or geographic name as entry element Epigenetics.
Source of heading or term fast
Authority record control number (OCoLC)fst01893642
9 (RLIN) 63841
Topical term or geographic name as entry element Pharmacogenetics.
Source of heading or term fast
Authority record control number (OCoLC)fst01060243
9 (RLIN) 63842
Topical term or geographic name as entry element Pharmacogenomics.
Source of heading or term fast
Authority record control number (OCoLC)fst01060245
9 (RLIN) 63843
Topical term or geographic name as entry element Pharmacogenetics.
9 (RLIN) 63844
Topical term or geographic name as entry element Epigenomics.
9 (RLIN) 63845
Topical term or geographic name as entry element Epigenesis, Genetic.
9 (RLIN) 63846
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Translational epigenetics series ;
Volume number/sequential designation v. 10.
9 (RLIN) 63847
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified ELSEVIER
Uniform Resource Identifier <a href="https://www.sciencedirect.com/science/book/9780128139394">https://www.sciencedirect.com/science/book/9780128139394</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type eBooks

No items available.